The Company develops, manufactures and sells diagnostic systems, including reagents and instruments, for the point-of-care and clinical testing sectors. The products are used in Europe and the United States for the detection, monitoring and control of infectious and sexually transmitted diseases, autoimmune diseases, hemoglobin disorders and diabetes. The Company sells its products directly and through a network of international distributors and strategic partners.